BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan...
BGM Group FY25 net loss widens to $19.94 million; net revenue rises 34% to $37.92 million
BGM Group shareholders approve share consolidation plan
Falco Resources receives $1.25 million from warrant exercises at $0.35 per share
BGM Group announces extraordinary shareholder meeting
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Thursday's Intraday Session